James Francis Winschel
Finanzdirektor/CFO bei Hamlin Scientific Corp.
Profil
James Francis Winschel is currently a Non-Executive Director at hVIVO Services Ltd., a Director at Cambridge Science Corp., a Director at Vivtex Corp., and the Chief Financial Officer at Hamlin Scientific Corp.
He previously worked as a Director at Cambrex Corp., an Independent Non-Executive Director at hVIVO Ltd., the Vice President-Finance at Caremark International, Inc., the Chief Financial Officer & Senior Vice President at PAREXEL International Corp., the Chief Financial Officer & Vice President at Whirlpool Financial Corp., the Chief Financial Officer & Executive Vice President at BTM Capital Corp., and the Chief Financial Officer at NovImmune SA. He also served as the President of U.B.
Vehicle Leasing, Inc. and the Chief Financial Officer at The Bank of Tokyo-Mitsubishi, Ltd.
Mr. Winschel holds an undergraduate degree and an MBA from Syracuse University.
Aktive Positionen von James Francis Winschel
| Unternehmen | Position | Beginn |
|---|---|---|
hVIVO Services Ltd.
 hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford. | Direktor/Vorstandsmitglied | 01.10.2014 |
| Vivtex Corp. | Direktor/Vorstandsmitglied | 01.01.2018 |
| Hamlin Scientific Corp. | Finanzdirektor/CFO | - |
Cambridge Science Corp.
 Cambridge Science Corp. BiotechnologyHealth Technology Cambridge Science Corp. engages in investing in the medicine. It also engages in improving patient lives through the acceleration of translational research and develops internal drug development programs. The firm finances and manages biotech companies commercializing novel technologies developed in the labs and the research institutions. The company was founded in 2017 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von James Francis Winschel
| Unternehmen | Position | Ende |
|---|---|---|
| HVIVO PLC | Direktor/Vorstandsmitglied | 17.01.2020 |
| PAREXEL INTERNATIONAL CORPORATION | Finanzdirektor/CFO | 01.09.2013 |
| U.B. Vehicle Leasing, Inc. | Präsident | 01.05.2000 |
| BTM Capital Corp. | Finanzdirektor/CFO | 01.09.1999 |
The Bank of Tokyo-Mitsubishi, Ltd.
 The Bank of Tokyo-Mitsubishi, Ltd. Regional BanksFinance Part of Mitsubishi UFJ Financial Group, Inc., The Bank of Tokyo-Mitsubishi Ltd. provides banking and financial services. The company is based in Tokyo, Japan. | Finanzdirektor/CFO | 01.01.1998 |
Ausbildung von James Francis Winschel
| Syracuse University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
| Caremark International, Inc. | Health Services |
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
hVIVO Ltd.
 hVIVO Ltd. Miscellaneous Commercial ServicesCommercial Services hVIVO Ltd. engages in the provision of clinical development services with a focus on human disease models. It specializes in human challenge studies using influenza, human rhinovirus, and respiratory syncytial virus for pharmaceutical and biotech companies. The company was founded by John Sidney Oxford in 1989 and is headquartered in London, the United Kingdom. | Commercial Services |
Whirlpool Financial Corp.
 Whirlpool Financial Corp. Investment ManagersFinance Part of Whirlpool Corp., Whirlpool Financial Corp. provides financial advisory services. | Finance |
| BTM Capital Corp. | Finance |
Novimmune SA
 Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
| U.B. Vehicle Leasing, Inc. | |
hVIVO Services Ltd.
hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford. | Technology Services |
The Bank of Tokyo-Mitsubishi, Ltd.
The Bank of Tokyo-Mitsubishi, Ltd. Regional BanksFinance Part of Mitsubishi UFJ Financial Group, Inc., The Bank of Tokyo-Mitsubishi Ltd. provides banking and financial services. The company is based in Tokyo, Japan. | Finance |
Cambridge Science Corp.
Cambridge Science Corp. BiotechnologyHealth Technology Cambridge Science Corp. engages in investing in the medicine. It also engages in improving patient lives through the acceleration of translational research and develops internal drug development programs. The firm finances and manages biotech companies commercializing novel technologies developed in the labs and the research institutions. The company was founded in 2017 and is headquartered in Cambridge, MA. | Health Technology |
| Hamlin Scientific Corp. | |
| Vivtex Corp. |
